Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Deffered Revenue (2017 - 2021)

Catheter Precision (VTAK) has disclosed Non-Current Deffered Revenue for 5 consecutive years, with $566000.0 as the latest value for Q2 2021.

  • On a quarterly basis, Non-Current Deffered Revenue fell 33.1% to $566000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $566000.0, a 33.1% decrease, with the full-year FY2020 number at $686000.0, down 44.32% from a year prior.
  • Non-Current Deffered Revenue was $566000.0 for Q2 2021 at Catheter Precision, down from $617000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.2 million in Q4 2019 to a low of $566000.0 in Q2 2021.
  • A 5-year average of $853153.8 and a median of $775000.0 in 2017 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: surged 60.63% in 2019, then tumbled 44.32% in 2020.
  • Catheter Precision's Non-Current Deffered Revenue stood at $775000.0 in 2017, then decreased by 1.03% to $767000.0 in 2018, then soared by 60.63% to $1.2 million in 2019, then crashed by 44.32% to $686000.0 in 2020, then dropped by 17.49% to $566000.0 in 2021.
  • Per Business Quant, the three most recent readings for VTAK's Non-Current Deffered Revenue are $566000.0 (Q2 2021), $617000.0 (Q1 2021), and $686000.0 (Q4 2020).